Table 2.
Antimicrobial activity of TZEO obtained by disc diffusion assay displayed in mm.
| Microorganism | Inhibition Zone a | ATB b |
|---|---|---|
| Gram-positive bacteria | ||
| Listeria monocytogenes | 9.00 ± 1.00 | 23.33 ± 0.08 |
| Micrococcus luteus | 6.67 ± 0.58 | 25.67 ± 0.03 |
| Staphylococcus aureus | 5.67 ± 0.58 | 27.33 ± 0.04 |
| Gram-negative bacteria | ||
| Enterobacter aerogenes | 12.33 ± 0.58 | 21.67 ± 0.03 |
| Escherichia coli | 7.33 ± 0.58 | 24.67 ± 0.02 |
| Pseudomonas putida | 4.67 ± 0.58 | 27.33 ± 0.04 |
| Yeasts | ||
| Candida albicans | 8.67 ± 0.58 | 25.67 ± 0.03 |
| Candida glabrata | 3.33 ± 0.58 | 28.67 ± 0.03 |
| Candida krusei | 8.67 ± 0.58 | 27.67 ± 0.04 |
| Candida tropicalis | 6.67 ± 0.58 | 24.67 ± 0.02 |
a Inhibition zones are presented in mm. b Antibiotics (ATB) used as a control are the following: cefoxitin for G− bacteria, gentamicin for G+ bacteria, and fluconazole for yeasts.